Outpatient cancer clinics received a 3-month reprieve before Medicare institutes its new prospective payment system, which is expected to result in a big drop in reimbursement for some newer cancer drugs.
Outpatient cancer clinics received a 3-month reprievebefore Medicare institutes its new prospective payment system, which is expectedto result in a big drop in reimbursement for some newer cancer drugs.
TheCenters for Medicare & Medicaid Services (CMS) expected the new rates tobecome effective on January 1, 2002. The Association of Community Cancer Centershad been pressing for the delay and for a revamping of the formula Medicare usedto determine new payments for some cancer drugs.
Stay up to date on recent advances in the multidisciplinary approach to cancer.